Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rishi Nanda
Observed name:
RISHI NANDA
Institutions:
University of Nevada, Las Vegas,
Indian Council of Agricultural Research,
Indian Veterinary Research Institute
Observed institutions:
University of Nevada, Las Vegas,
Indian Council of Agricultural Research,
Indian Veterinary Research Institute,
Sarcoma Oncology Center,
Touro University Nevada
ORCID:
0009-0007-1316-1072
Observed ORCID:
0009-0007-1316-1072
OpenAlex ID:
A5091278195
Trabectedin for advanced soft-tissue sarcoma: A single-center experience of over 10 years.
2016
·
Imran Syed
, Madhuri Sudan
, et al.
·
Journal of Clinical Oncology
·
5
Incidence of cardiac toxicities in patients with hematologic malignancies treated with zanubrutinib compared to control, including BTK inhibitor (Ibrutinib): A meta-analysis of randomized controlled trials
2025
·
Abbas Hussain
, Daniel Jones
, et al.
·
Blood
·
1
Knowledge and Attitude Regarding Antibiotic Resistance among Dental Students and Practitioners in Rajasthan Region
2026
·
Rishi Nanda
, Saini Vaibhav
, et al.
·
Advances in Research
CLL-1196: Pirtobrutinib Following Covalent BTK Inhibitor Exposure in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Pooled Analysis
2026
·
Rishi Nanda
, Daniel Jones
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CLL-1196: Pirtobrutinib Following Covalent BTK Inhibitor Exposure in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Pooled Analysis
2026
·
Rishi Nanda
, Daniel Jones
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CLL-1272: Hematologic Toxicity and Treatment Discontinuation With Venetoclax-Based Regimens in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials
2026
·
Rishi Nanda
, Daniel Jones
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CLL-1272: Hematologic Toxicity and Treatment Discontinuation With Venetoclax-Based Regimens in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials
2026
·
Rishi Nanda
, Daniel Jones
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CLL-1282: Cardiovascular and Treatment Discontinuation Outcomes With Next-Generation BTK Inhibitors in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials
2026
·
Rishi Nanda
, Daniel Jones
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CLL-1282: Cardiovascular and Treatment Discontinuation Outcomes With Next-Generation BTK Inhibitors in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials
2026
·
Rishi Nanda
, Daniel Jones
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Dynamic regulation of porcine luteal physiology by fibroblast growth factors: expression patterns and FGF2 modulation in-vitro
2026
·
Rishi Nanda
, V. S. Chouhan
, et al.
·
Veterinary Research Communications
Knowledge, Awareness, and Preventive Practices Regarding Radiation-Induced Caries among Dental Students and Practitioners: A Cross-Sectional Survey
2026
·
Sarita Gill
, Pradipkumar Damor
, et al.
·
Book Publisher International (a part of SCIENCEDOMAIN International)
Abstract 4367292: Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Risk of Cardiac Adverse Events in Patients with Non-small Cell Lung Cancer Treated with Osimertinib Compared to Control
2025
·
Zin Win
, Abbas Hussain
, et al.
·
Circulation
Incidence of bleeding and hypertension in patients with hematologic malignancies treated with next-generation Bruton tyrosine kinase (BTK) inhibitors: A meta-analysis of randomized controlled trials
2025
·
Jason Ta
, Abbas Hussain
, et al.
·
Blood
Incidence of cardiac events associated with next-generation bruton tyrosine kinase (BTK) inhibitors compared to control in hematologic malignancies: A meta-analysis of randomized trials
2025
·
Ramaditya Srinivasmurthy
, Abbas Hussain
, et al.
·
Blood
Incidence of second primary malignancies in patients with hematologic malignancies treated with next-generation bruton tyrosine kinase (BTK) inhibitors: A meta-analysis of randomized controlled trials
2025
·
Rishi Nanda
, Daniel Jones
, et al.
·
Blood
PDF
Artificial Intelligence in dentistry: An upcoming asset
2025
·
RISHI NANDA
·
University Journal of Dental Sciences
PDF
Show more works
View as search
Works count:
16
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type